Lung metastases

Area of Science:

• Oncology
• Cancer Metastasis Research
• Pulmonary Medicine

Background:

• Lung metastases affect up to 50% of patients with metastatic cancer, leading to poor prognosis.
• These metastases impair patient quality of life through symptoms like dyspnea and pain.
• The development of lung metastases involves complex tumor-secreted factors and microenvironment alterations.

Purpose of the Study:

• To review the mechanisms of lung metastasis formation.
• To discuss diagnostic approaches for lung metastases.
• To highlight current treatment strategies and future therapeutic directions.

Main Methods:

• Literature review of mechanisms driving lung metastasis.
• Analysis of diagnostic methods including imaging and histology.
• Synthesis of information on current and potential treatments for lung metastases.

Main Results:

• Tumor factors (VEGF, TGFβ, CCL2), exosomes, and microparticles promote a pre-metastatic niche in the lungs.
• Diagnosis relies on imaging, with histology sometimes needed to differentiate from primary lung cancer.
• Treatment decisions consider metastasis characteristics and patient condition, often involving systemic therapy.

Conclusions:

• Understanding pre-metastatic niche formation is crucial for developing novel prevention and treatment strategies.
• Targeted therapies for lung metastases remain an unmet clinical need.
• Future research into metastasis stages may yield tailored treatments.